Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase 1 17Phase 3 16Phase 1/2 14Phase NA 7Phase 2/3 4Phase EARLY_PHASE1 2

Status

Unknown 4Recruiting 4Not yet recruiting 3Completed 2Withdrawn 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Stomach Neoplasms 12Colorectal Neoplasms 12Breast Neoplasms 12Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Neoplasm Metastasis 9Lung Neoplasms 9Hematologic Neoplasms 9Head and Neck Neoplasms 9Carcinoma, Hepatocellular 9Squamous Cell Carcinoma of Head and Neck 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Neoplasms 8Endometrial Neoplasms 8Myasthenia Gravis 7Melanoma 7Uterine Cervical Neoplasms 6Recurrence 6Rectal Neoplasms 6Neoplasms by Site 6Neoplasms by Histologic Type 6Lymphoma 6Leukemia 6Urinary Bladder Neoplasms 5Neoplasms, Plasma Cell 5Infections 5Colonic Neoplasms 5

Interventions

Radiotherapy 2tislelizumab 1spartalizumab 1pembrolizumab 1anlotinib 1TP protocol 1Neoadjuvant Therapy 1Immunotherapy 1Drug Therapy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Esophageal Squamous Cell Carcinoma × Clear all
NCT06907602 2025-04-02

ONTRESCC

Peking Union Medical College Hospital

Phase 2/3 Recruiting
120 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06138028 2024-07-24

Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

Qingdao Central Hospital

Phase 2/3 Recruiting
90 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06354530 2024-04-09

A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Army Medical Center of PLA

Phase 2/3 Recruiting
266 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04973306 2022-06-30

iCROSS

Shanghai Zhongshan Hospital

Phase 2/3 Recruiting
176 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡